News > Biocon developing 20 biosimilar products for global markets

Biocon developing 20 biosimilar products for global markets

Fortuneindia | 27/01/2022 03:42 PM | Click to read full article

India's premier biopharmaceutical company Biocon is working on a pipeline of 20 biosimilar drugs or similar but not identical copy of biologic medicines, to tap the upcoming huge opportunity.

Biocon, which launched the world's first interchangeable insulin Glargine in the US during the third quarter, has eight approved products.

-